Immunogenetics of new onset diabetes after transplantation in Kuwait Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy

Introduction and aim: New onset diabetes after transplantation (NODAT) is a serious metabolic complication following kidney transplantation. Although beta-cell dysfunction is considered the main contributing factor in the development of this complication, its exact etiology is yet to be identi fi ed. We aimed to investigate NODATamong kidney transplant cohort in Kuwait with special stress on correlation between its risk factors and interferon gamma genotyping. Materials and methods: We surveyed 309 kidney transplant recipients from Hamed Al Essa Transplantation Centre, Kuwait. The participants were categorized into cohorts according to the development of NODAT diagnosed based on the American Diabetes Association guidelines. Statistical analyses were performed using SPSS software. We genotyped interferon gamma as the leading immunosignature for T lymphocyte. Results: No relationship between ethnicity and the development of NODAT was identi fi ed. However, there was a signi fi cant difference in age between cohorts. Younger patients demonstrated a lower rate of NODAT while, NODAT reached its maximum in 40 – 60-year age group. IFNG TT genotype was signi fi cantly associated with NODAT ( p =0.005), while IFNG AA was considerably higher in the non-NODAT group. Conclusion: Beside the conventional contributing factors of NODAT, our results might represent a suitable platform for a larger cytokine and chemokine spectrum genotyping.

[1]  T. Zhu,et al.  Effects of preoperative hepatitis B virus infection, hepatitis C virus infection, and coinfection on the development of new‐onset diabetes after kidney transplantation , 2018, Journal of diabetes.

[2]  S. Anticoli,et al.  Sex-Dependent Outcome of Hepatitis B and C Viruses Infections: Synergy of Sex Hormones and Immune Responses? , 2018, Front. Immunol..

[3]  Eugenia G. Giannopoulou,et al.  Interferon‐&ggr; Represses M2 Gene Expression in Human Macrophages by Disassembling Enhancers Bound by the Transcription Factor MAF , 2017, Immunity.

[4]  O. Vittecoq,et al.  Rheumatoid arthritis, insulin resistance, and diabetes. , 2017, Joint, bone, spine : revue du rhumatisme.

[5]  P. Reinke,et al.  Diabetic kidney transplant recipients: Impaired infection control and increased alloreactivity , 2017, Clinical transplantation.

[6]  Rajan K. Patel,et al.  Renal association clinical practice guideline in post-operative care in the kidney transplant recipient , 2017, BMC Nephrology.

[7]  T. Ecder,et al.  The incidence of new onset diabetes after transplantation and related factors: Single center experience. , 2017, Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia.

[8]  A. Mirzazadeh,et al.  Higher incidence of HCV in females compared to males who inject drugs: A systematic review and meta‐analysis , 2017, Journal of viral hepatitis.

[9]  R. Lechler,et al.  Graft dysfunction in chronic antibody-mediated rejection correlates with B-cell–dependent indirect antidonor alloresponses and autocrine regulation of interferon-γ production by Th1 cells , 2017, Kidney international.

[10]  M. Shoukri,et al.  New-onset diabetes after kidney transplantation: Incidence, risk factors, and outcomes. , 2016, Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia.

[11]  P. Galajda,et al.  Correlation between CMV Infection and Post-transplantation New-onset Diabetes Mellitus , 2016, International journal of organ transplantation medicine.

[12]  Hyosang Kim,et al.  Risk factors for new-onset diabetes mellitus after living donor kidney transplantation in Korea - a retrospective single center study , 2016, BMC Nephrology.

[13]  W. Malorni,et al.  Organ transplantation and gender differences: a paradigmatic example of intertwining between biological and sociocultural determinants , 2016, Biology of Sex Differences.

[14]  A. Akl,et al.  New Onset Diabetes Mellitus after Living Donor Renal Transplantation: A Unique Pattern in the Egyptian Population , 2015 .

[15]  A. Tura,et al.  Glucose Metabolism After Renal Transplantation , 2013, Diabetes Care.

[16]  S. Seif,et al.  Interleukin-12B gene polymorphism frequencies in Egyptians and sex-related susceptibility to hepatitis C infection. , 2013, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[17]  A. El-Agroudy,et al.  Risk factors and outcomes of new-onset diabetes after transplant: single-centre experience. , 2012, Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation.

[18]  J. Maher,et al.  Assessment of factors associated with pre‐diabetes in HCV infection including direct and dynamic measurements of insulin action , 2012, Journal of viral hepatitis.

[19]  A. Munshi,et al.  Cytokine gene polymorphisms in the susceptibility to acute coronary syndrome. , 2012, Genetic testing and molecular biomarkers.

[20]  Sung Wook Kang,et al.  Polymorphisms of the Interferon gamma gene and coronary artery disease in the Korean population , 2012, Molecular Biology Reports.

[21]  M. Arias,et al.  Prediction at First Year of Incident New-Onset Diabetes After Kidney Transplantation by Risk Prediction Models , 2012, Diabetes Care.

[22]  G. Darlington,et al.  Elevated interferon gamma signaling contributes to impaired regeneration in the aged liver. , 2011, The journals of gerontology. Series A, Biological sciences and medical sciences.

[23]  M. Arias,et al.  Early prediction of new-onset diabetes mellitus by fifth-day fasting plasma glucose, pulse pressure, and proteinuria. , 2011, Transplantation proceedings.

[24]  G. Chrousos,et al.  Diabetes mellitus type 2 and other chronic non-communicable diseases in the central region, Saudi Arabia (riyadh cohort 2): a decade of an epidemic , 2011, BMC medicine.

[25]  B. Kahan,et al.  New-onset diabetes after renal transplantation: diagnosis, incidence, risk factors, impact on outcomes, and novel implications. , 2011, Transplantation proceedings.

[26]  G. Oxenkrug.  Interferon-gamma - Inducible Inflammation: Contribution to Aging and Aging-Associated Psychiatric Disorders. , 2011, Aging and disease.

[27]  S. Pham,et al.  New onset diabetes after transplantation (NODAT): an overview , 2011, Diabetes, metabolic syndrome and obesity : targets and therapy.

[28]  S. Adamopoulos,et al.  Cytokine gene polymorphisms are associated with markers of disease severity and prognosis in patients with idiopathic dilated cardiomyopathy. , 2011, Cytokine.

[29]  C. Gorodezky,et al.  Multiple sclerosis risk markers in HLA-DRA, HLA-C, and IFNG genes are associated with sex-specific childhood leukemia risk , 2010, Autoimmunity.

[30]  N. Manley,et al.  An evolutionary perspective on the mechanisms of immunosenescence. , 2009, Trends in immunology.

[31]  M. Arababadi,et al.  Evaluation of IFN-gamma serum level in nephropatic type 2 diabetic patients. , 2009, Pakistan journal of biological sciences : PJBS.

[32]  S. Chadban,et al.  Immunosuppression in renal transplantation: some aspects for the modern era. , 2008, Transplantation reviews.

[33]  B. Bammens,et al.  Early clinical assessment of glucose metabolism in renal allograft recipients: diagnosis and prediction of post-transplant diabetes mellitus (PTDM). , 2008, Nephrology, Dialysis and Transplantation.

[34]  S. Chadban.  New-onset diabetes after transplantation--should it be a factor in choosing an immunosuppressant regimen for kidney transplant recipients. , 2008, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[35]  D. Abramowicz,et al.  Conversion from tacrolimus to cyclosporine A for new‐onset diabetes after transplantation: a single‐centre experience in renal transplanted patients and review of the literature , 2007, Transplant international : official journal of the European Society for Organ Transplantation.

[36]  S. Chadban,et al.  Results of an International, Randomized Trial Comparing Glucose Metabolism Disorders and Outcome with Cyclosporine Versus Tacrolimus , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[37]  J. Pascual,et al.  Ischemic heart disease after renal transplantation in patients on cyclosporine in Spain. , 2006, Journal of the American Society of Nephrology : JASN.

[38]  G. Biolo,et al.  Association of interferon-gamma +874A polymorphism with reduced long-term inflammatory response in haemodialysis patients. , 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[39]  A. Hartmann,et al.  The impact of early-diagnosed new-onset post-transplantation diabetes mellitus on survival and major cardiac events. , 2006, Kidney international.

[40]  S. Klein,et al.  Host factors mediating sex differences in viral infection. , 2005, Gender medicine.

[41]  S. Puumala,et al.  New-Onset Diabetes after Kidney Transplantation: An Application of 2003 International Guidelines , 2005, Transplantation.

[42]  Jian-She Wang,et al.  Relationship between cytokines gene polymorphism and susceptibility to hepatitis B virus intrauterine infection. , 2005, Chinese medical journal.

[43]  H. Ikeda,et al.  Aberrant gene expression by CD25+CD4+ immunoregulatory T cells in autoimmune-prone rats carrying the human T cell leukemia virus type-I gene. , 2005, International immunology.

[44]  M. Kessler,et al.  Factors influencing the onset of diabetes mellitus after kidney transplantation: a single French center experience. , 2005, Transplantation proceedings.

[45]  T. Egeland,et al.  Asymptomatic cytomegalovirus infection is associated with increased risk of new-onset diabetes mellitus and impaired insulin release after renal transplantation , 2004, Diabetologia.

[46]  H. Volk,et al.  Nonimmunologic complications and gene polymorphisms of immunoregulatory cytokines in long-term renal transplants. , 2004, Kidney international.

[47]  M. Schnitzler.  Diabetes Mellitus After Kidney Transplantation in the United States , 2003, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[48]  Bertram L Kasiske,et al.  New-onset diabetes after transplantation: 2003 International consensus guidelines. Proceedings of an international expert panel meeting. Barcelona, Spain, 19 February 2003. , 2003, Transplantation.

[49]  R. Gupta,et al.  High incidence of post-transplant diabetes mellitus in Kuwait. , 2002, Diabetes research and clinical practice.

[50]  I. Mühlhauser,et al.  Evidence‐based patient information in diabetes , 2000, Diabetic medicine : a journal of the British Diabetic Association.

[51]  A. Stevens,et al.  A single nucleotide polymorphism in the first intron of the human IFN-gamma gene: absolute correlation with a polymorphic CA microsatellite marker of high IFN-gamma production. , 2000, Human immunology.

[52]  C. Franceschi,et al.  Inflamm‐aging: An Evolutionary Perspective on Immunosenescence , 2000 .

[53]  A. Demaine,et al.  A CA repeat polymorphism of the IFN-gamma gene is associated with susceptibility to type 1 diabetes. , 2000, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[54]  A. Demaine,et al.  A study of cytokine protein secretion, frequencies of cytokine expressing cells and IFN-G gene polymorphisms in normal individuals. , 1999, Transplantation.

[55]  A. Hajeer,et al.  In vitro production of IFN-gamma correlates with CA repeat polymorphism in the human IFN-gamma gene. , 1999, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.

[56]  E. Friedman,et al.  Diabetes mellitus after renal transplantation: as deleterious as non-transplant-associated diabetes? , 1998, Transplantation.

[57]  M. Russell,et al.  Reduced transplant arteriosclerosis in murine cardiac allografts placed in interferon-gamma knockout recipients. , 1998, The American journal of pathology.

[58]  M. Casey,et al.  New-onset diabetes after kidney transplantation: can the risk be modified by choosing immunosuppression regimen based on pretransplant viral serology? , 2018, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[59]  S. Raptis,et al.  Correlation between intracellular interferon-gamma (IFN-gamma) production by CD4+ and CD8+ lymphocytes and IFN-gamma gene polymorphism in patients with type 2 diabetes mellitus and latent autoimmune diabetes of adults (LADA). , 2005, Cytokine.

[60]  B. Kasiske,et al.  NEW-ONSET DIABETES AFTER TRANSPLANTATION: 2003 INTERNATIONAL CONSENSUS GUIDELINES , 2003 .

[61]  S. Wallenstein,et al.  Higher incidence of diabetes in liver transplant recipients with hepatitis C. , 1998, Journal of clinical gastroenterology.

[62]  A. Billiau,et al.  Interferon-gamma: biology and role in pathogenesis. , 1996, Advances in immunology.